INT131
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for INT131, covering 2018-02-28 to 2018-02-28. Get the full timeline:
Most recent: Clinical Trial Update: This is a Randomized Study Comparing Two Doses of INT131 ( 3 mg and 1 mg) Administered Orally (PO) Daily (QD) Versus Placebo 1 Tablet PO QD in Subjects With Treatment-naïve RRMS for ≤ 3 Years [Phase 2]